GlassScriptPhysician profile
Amanda R Thatcher
NPI 1407518814
$677.99
in general payments reported to CMS, 2019-2025
18 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.59 · 2022: $105 · 2023: $182 · 2024: $223 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $156.95 | 2021-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $72.37 | 2022-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Novo Nordisk INC | $62.58 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $48.23 | 2024 | Flumist Quadrivalent, Farxiga |
| Glaxosmithkline, LLC. | $43.51 | 2023-2024 | Bexsero, Pediarix |
| Ironshore Pharmaceuticals INC. | $35.47 | 2024 | |
| Sanofi Pasteur INC. | $33.71 | 2024 | |
| Axsome Therapeutics, INC. | $29.42 | 2025 | Auvelity |
| Corium, LLC | $29.05 | 2022-2023 | Azstarys |
| Pfizer INC. | $23.52 | 2024 | |
| Alexion Pharmaceuticals, INC. | $21.65 | 2023 | Strensiq |
| Exact Sciences Corporation | $21.38 | 2025 | Cologuard Collection Kit |
| Seqirus USA INC | $19.31 | 2024 | Flucelvax |
| Bayer Healthcare Pharmaceuticals INC. | $19.25 | 2025 | |
| Phadia US INC. | $17.86 | 2023 | Immunocap |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.15 | 2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $14.78 | 2025 | Freestyle Libre 3 |
| Tris Pharma INC | $13.80 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Thatcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.